Cargando…
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
Potential therapeutic approaches in coronavirus disease 2019 (COVID-19) comprise antiviral and immunomodulatory agents; however, no immunomodulator drug has been approved. This multicenter, prospective, open-label, uncontrolled study aimed to assess the use of subcutaneous tocilizumab in adult patie...
Autores principales: | Malekzadeh, Reza, Abedini, Atefeh, Mohsenpour, Behzad, Sharifipour, Ehsan, Ghasemian, Roya, Javad-Mousavi, Seyed Ali, Khodashahi, Rozita, Darban, Mahboobeh, Kalantari, Saeed, Abdollahi, Nafiseh, Salehi, Mohammad Reza, Rezaei Hosseinabadi, Abbas, Khorvash, Farzin, Valizadeh, Melika, Dastan, Farzaneh, Yousefian, Sahar, Hosseini, Hamed, Anjidani, Nassim, Tabarsi, Payam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553010/ https://www.ncbi.nlm.nih.gov/pubmed/33075713 http://dx.doi.org/10.1016/j.intimp.2020.107102 |
Ejemplares similares
-
Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
por: Barati, Saghar, et al.
Publicado: (2021) -
Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021) -
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
por: Dastan, Farzaneh, et al.
Publicado: (2020) -
The Effect of acetyl-L-carnitine, Alpha-lipoic Acid, and Coenzyme Q10 Combination in Preventing Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized, Double-blind, Placebo-controlled Clinical Trial
por: Hakimizad, Reza, et al.
Publicado: (2021) -
Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
por: Baghaei, Parvaneh, et al.
Publicado: (2021)